Shuttle Pharma Provides First Quarter 2024 Corporate Update

by B2i | May 14, 2024 | Press Releases

GAITHERSBURG, Md., May 14, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation...

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1×1 Meetings on Thursday, May 2, 2024

by B2i | Apr 23, 2024 | Press Releases

GAITHERSBURG, Md., April 23, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (“RT”),...

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

by B2i | Apr 3, 2024 | Press Releases

Webcasted presentation to take place at 3:10pm ETGAITHERSBURG, Md., April 03, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients...

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

by B2i | Mar 22, 2024 | Press Releases

GAITHERSBURG, Md., March 22, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation...

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024

by B2i | Mar 5, 2024 | Press Releases

Webcast presentation to take place at 11:25am ETROCKVILLE, Md., March 05, 2024 — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients...